Epigenetic mechanisms in alcohol- and adversity-induced developmental origins of neurobehavioral functioning von Boschen, K.E., Keller, S.M., Roth, T.L., Klintsova, A.Y.

Volltext

A Survey of Emergency Physician Use of Bedside Ultrasound in North Carolina von Noste, E.E, Tayal, V.S, Keller, S.M

Volltext

Central Vascular Catheter Placement Evaluation Using Saline Flush and Bedside Echocardiography von Weekes, A.J, Keller, S.M, Johnson, D.A, Efune, B, Carey, C, Rozario, N, Norton, H.J

Volltext

P 38. Mild cognitive impairment in patients with Parkinson's disease is characterized by a strong coupling of EEG signal complexity and band power von Keller, S.M., Beltrani, S., Gschwandtner, U., Meyer, A., Toloraia, K., Fuhr, P.

Volltext

Immunohistochemical Detection of Survivin in Canine Lymphoma von Wimmershoff, J., Polkinghorne, A., Grest, P., Schade, B., Marchal, T., Keller, S.M., Guscetti, F.

Volltext

1210P Neoadjuvant pembrolizumab (pembro) or placebo (pbo) plus chemotherapy and adjuvant pembro or pbo for early stage NSCLC: Subgroup analyses of the phase III KEYNOTE-671 study von Garassino, M.C., Gao, S., Liberman, M., Spicer, J.D., Chen, K., Vanakesa, T., Thiberville, L., Chaves, F.D.F., Liu, G., Okada, M., Saji, H., Laktionov, K., Rittmeyer, A., Bosch-Barrera, J., Gentzler, R.D., Ganti, A.K., Jensen, E., Keller, S.M., Samkari, A., Wakelee, H.

Volltext

FV22 Reduced Tsallis Entropy of EEG in Patients with Parkinsons Disease – A Predictive Marker for Cognitive Decline von Keller, S.M., Gschwandtner, U., Meyer, A., Chaturvedi, M., Fuhr, P., Roth, V.

Volltext

Comprehensive Test System to Identify Suitable Antibodies Against p53 for Immunohistochemical Analysis of Canine Tissues von Keller, S.M, Schade, B, Rickenbacher, A.B, Brugnera, E, Wergin, M.C, Müller, E.J, Suter, M.M, Guscetti, F

Volltext

LBA56 Overall survival in the KEYNOTE-671 study of perioperative pembrolizumab for early-stage non-small-cell lung cancer (NSCLC) von Spicer, J.D., Gao, S., Liberman, M., Kato, T., Tsuboi, M., Lee, S-H., Chen, K-N., Dooms, C., Majem, M., Eigendorff, E., Martinengo, G., Bylicki, O., Garassino, M.C., Rodriguez Abreu, D., Chaft, J., Novello, S., Yang, J., Keller, S.M., Samkari, A., Wakelee, H.

Volltext

1235TiP Perioperative pembrolizumab + platinum-based chemotherapy for resectable locally advanced non-small cell lung cancer: The phase III KEYNOTE-671 study von Tsuboi, M., Luft, A., Ursol, G., Kato, T., Levchenko, E., Eigendorff, E., Berard, H., Zurawski, B., Demedts, I., Garassino, M.C., Yang, J., Makarious, K., Keller, S.M., Wakelee, H.A.

Volltext

OA01.03 Association of Pathologic Regression with EFS in the KEYNOTE-671 Study of Perioperative Pembrolizumab for Early-Stage NSCLC von Jones, D.R., Wakelee, H., Spicer, J.D., Liberman, M., Kato, T., Tsuboi, M., Lee, S.-H., Wang, W., Chen, H., Dooms, C., Majem, M., Eigendorff, E., Martinengo, G.L., Bylicki, O., Huang, H.-C., Novello, S., Jensen, E., Keller, S.M., Samkari, A., Kalhor, N.

Volltext

OA02.03 Pembrolizumab Plus Platinum Chemotherapy and Radiotherapy in Unresectable, Locally Advanced, Stage III NSCLC: KEYNOTE-799 von Reck, M., Lee, K.h., Frost, N., Kowalski, D.M., Breder, V., Pollock, T., Reguart, N., Houghton, B., Quantin, X., Keller, S.m., Liu, H., Piperdi, B., Jabbour, S.K.

Volltext

930MO PD-L1 expression and outcomes of pembrolizumab and placebo in completely resected stage IB-IIIA NSCLC: Subgroup analysis of PEARLS/KEYNOTE-091 von Peters, S., Besse, B., Marreaud, S., Dafni, U., Oselin, K., Havel, L., Esteban Gonzalez, E., Isla, D., Martinez-Marti, A., Faehling, M., Tsuboi, M., Lee, J-S., Nakagawa, K., Yang, J., Keller, S.M., Mauer, M.E., Jha, N., Stahel, R.A., Paz-Ares, L., O'Brien, M.E.R.

Volltext

VP3-2022: Pembrolizumab (pembro) versus placebo for early-stage non-small cell lung cancer (NSCLC) following complete resection and adjuvant chemotherapy (chemo) when indicated: Ra... von Paz-Ares, L., O'Brien, M.E.R., Mauer, M., Dafni, U., Oselin, K., Havel, L., Esteban Gonzalez, E., Isla, D., Martinez-Marti, A., Faehling, M., Tsuboi, M., Lee, J-S., Nakagawa, K., Yang, J., Keller, S.M., Jha, N., Marreaud, S.I., Stahel, R.A., Peters, S., Besse, B.

Volltext

Sensitivity and Specificity of Canine Pancreas-Specific Lipase (cPL) and Other Markers for Pancreatitis in 70 Dogs with and without Histopathologic Evidence of Pancreatitis von Trivedi, S., Marks, S.L., Kass, P.H., Luff, J.A., Keller, S.M., Johnson, E.G., Murphy, B.

Volltext

The influence of gender on survival and tumor recurrence following adjuvant therapy of completely resected stages II and IIIa non-small cell lung cancer von Keller, S.M, Vangel, M.G, Adak, S, Wagner, H, Schiller, J.H, Herskovic, A, Komaki, R, Perry, M.C, Marks, R.S, Livingston, R.B, Johnson, D.H

Volltext

120MO Adjuvant pembrolizumab versus placebo for early-stage NSCLC after resection and optional chemotherapy: Updated results from PEARLS/KEYNOTE-091 von Besse, B., Havel, L., Peters, S., Marreaud, S.I., Jha, N., Oselin, K., Esteban Gonzalez, E., Isla Casado, M.D., Martinez-Marti, A., Faehling, M., Lee, J-S., Luo, Y., Keller, S.M., Dafni, U., Mauer, M.E., Stahel, R.A., O'Brien, M.E.R., Tsuboi, M., Paz-Ares, L.

Volltext

Abscessation, osteomyelitis and fracture of the sternum in a cow von Braun, U., Keller, A., Muggli, E., Keller, S. M., Nuss, K.

Volltext

Validation of tissue microarrays for immunohistochemical analyses of canine lymphomas von Keller, S.M, Keller, B.C, Grest, P, Borger, C.T, Guscetti, F

Volltext

Immunohistochemistry for Markers of Proliferation and Apoptosis and Anti-apoptotic Bcl-2 Family Members in Canine Lymphoma von Nurbek, A., Zeller, S., Croci, M., Guscetti, P., Keller, S.M., Guscetti, F.

Volltext